Interim report
Page 1
Ref. No.: QHTL/Sec/SE/2026-27/55 October 27, 2026 To, To, The Manager, The Manager, Corporate Services, Corporate Services, BSE Limited, National Stock Exchange of India Limited, 14th Floor, P J Towers, Dalal Street, Exchange Plaza, Bandra Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Ref: Security ID: QUICKHEAL Symbol: QUICKHEAL Security Code: 539678 Series: EQ Subject: Outcome of Board Meeting held on October 27, 2026. Dear Sir / Madam, Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors at its meeting held on October 27, 2026, which commenced at 05:00 PM IST and concluded at 08:25 PM IST, has approved following: 1. Unaudited Consolidated and Standalone Financial Results of the Company for the quarter and half year ended September 30, 2026. 2. M S K A & Associates LLP, Chartered Accountants, Statutory Auditors of the Company, have issued a Limited Review Report with an unmodified opinion on the above-mentioned results. 3. Appointment of Internal Auditor for the Financial Year 2026-27. Details of the said appointment are enclosed as (Annexure A). 4. Appointment of Company Secretary and Key Managerial Personnel of the Company. Details of the said appointment are enclosed as (Annexure B). 5. Appointment of Nodal Officer of the Company. Details of the said appointment are enclosed as (Annexure C). Quick Heal Quick Heal Technologies Ltd. I Corporate Office: 3rd & 4'h Floor, lndiQube Orchid, Plot No. 3A, Shastrinagar, Loop Road, Yerawada, Pune 411 006, MH, INDIA. ~ Registered Office: CTS No. 1442 to 1445, Thube Park, Shivaji Nagar, Pune 41 1 005, MH, INDIA. %. +91 20 66813232 ig contactus@quickheal.com e www.quickhea l.com CIN - L72200MH1995PLC091408
Page 2
A copy of the Press Release and Investor Presentation in respect of the aforesaid Financial Results are enclosed herewith. This is for your information and records. Sincerely, For Quick Heal Technologies Limited Vikram Dhanani Compliance Officer Quick Heal Quick Heal Technologies Ltd. I Corporate Office: 3rd & 4th Floor, lndiQube Orchid, Plot No. 3A, Shastrinagar, Loop Road, Yerawada, Pune 411 006, MH, INDIA. (v Registered Office: CTS No. 1442 to 1445, Thube Park, Shivaji Nagar, Pune 411 005, MH, INDIA. -i.. +912066813232 ~ contactus@quickheal.com e www.quickheal.com CIN - L72200MH1995PLC091408
Page 3
ANNEXURE A Sr. No. Details of Event that needs to be provided Information of such events 1 Name of the Internal Auditor Grant Thornton Bharat LLP 2 Reason for change viz. appointment, re- appointment, resignation, removal, death or otherwise Appointment as an Internal Auditor 3 Date of appointment/re-appointment/cessation (as applicable) & term of appointment/re- appointment; October 27, 2026 4 Brief Profile (in case of appointment) Grant Thornton Bharat LLP (GT Bharat LLP) is a leading professional services firm in India and a member of the Grant Thornton International network. Established in its current LLP structure in 2012, the firm provides a wide range of services, including audit and assurance, internal audit, taxation, risk advisory, business consulting, regulatory compliance and financial advisory. 5 Disclosure of relationships between directors (in case of appointment of a director) Not Applicable 6 Information as required under BSE circular Number LIST/COM/14/2018-19 and NSE circular no. NSE/CML/2018/24 dated 20th June, 2018 Not Applicable 7 Letter of resignation along with detailed reason for resignation Not Applicable 8 Names of listed entities in which the resigning Independent Director holds directorships, indicating the category of directorship and membership of board committees, if any. Not Applicable 9 The independent director shall, along with the detailed reasons, also provide a confirmation that there is no other material reasons other than those provided. Not Applicable 10 Confirmation in compliance with SEBI Letter dated June 14, 2018 read along with Exchange Circular dated June 20, 2018 (Affirmation that the person proposed to be appointed as Director is not debarred from holding the office by virtue of any SEBI Order or any other authority) Not Applicable Quick Heal Quick Heal Technologies Ltd. I Corporate Office: 3rd & 4'h Floor, lndiQube Orchid, Plot No. 3A, Shastrinagar, Loop Road, Yerawada, Pune 411 006, MH, INDIA. ~ Registered Office: CTS No. 1442 to 1445, Thube Park, Shivaji Nagar, Pune 41 1 005, MH, INDIA. %. +91 20 66813232 ig contactus@quickheal.com e www.quickhea l.com CIN - L72200MH1995PLC091408
Page 4
ANNEXURE B Sr. No. Details of Event that needs to be provided Information of such events 1 Name of the Director / KMP / Senior Management Personnel Mr. Shailesh Shinde 2 Reason for change viz. appointment, re- appointment, resignation, removal, death or otherwise Company Secretary and Key Managerial Personnel 3 Date of appointment/re-appointment/cessation (as applicable) & term of appointment/re- appointment; October 27, 2026 4 Brief Profile (in case of appointment) Mr. Shailesh Shinde is a qualified Company Secretary and Legal professional with over 18 years of experience in corporate secretarial, legal, compliance, FEMA, governance, and banking functions. He was previously associated with Piaggio Vehicles Private Limited as Company Secretary and Legal. 5 Disclosure of relationships between directors (in case of appointment of a director) Not Applicable 6 Information as required under BSE circular Number LIST/COM/14/2018-19 and NSE circular no. NSE/CML/2018/24 dated 20th June, 2018 Not Applicable 7 Letter of resignation along with detailed reason for resignation Not Applicable 8 Names of listed entities in which the resigning Independent Director holds directorships, indicating the category of directorship and membership of board committees, if any. Not Applicable 9 The independent director shall, along with the detailed reasons, also provide a confirmation that there is no other material reasons other than those provided. Not Applicable 10 Confirmation in compliance with SEBI Letter dated June 14, 2018 read along with Exchange Circular dated June 20, 2018 ( Affirmation that the person proposed to be appointed as Director is not debarred from holding the office by virtue of any SEBI Order or any other authority ) Not Applicable Quick Heal Quick Heal Technologies Ltd. I Corporate Office: 3rd & 4'h Floor, lndiQube Orchid, Plot No. 3A, Shastrinagar, Loop Road, Yerawada, Pune 411 006, MH, INDIA. ~ Registered Office: CTS No. 1442 to 1445, Thube Park, Shivaji Nagar, Pune 41 1 005, MH, INDIA. %. +91 20 66813232 ig contactus@quickheal.com e www.quickhea l.com CIN - L72200MH1995PLC091408
Page 5
ANNEXURE C Sr. No. Details of Event that needs to be provided Information of such events 1 Name of the Nodal Officer Mr. Shailesh Shinde 2 Reason for change viz. appointment, re- appointment, resignation, removal, death or otherwise Appointment as a Nodal Officer 3 Date of appointment/re- appointment/cessation (as applicable) & term of appointment/re-appointment; October 27, 2026 4 Brief Profile (in case of appointment) Mr. Shailesh Shinde is a qualified Company Secretary and Legal professional with over 18 years of experience in corporate secretarial, legal, compliance, FEMA, governance, and banking functions. He was previously associated with Piaggio Vehicles Private Limited as Company Secretary and Legal. 5 Disclosure of relationships between directors (in case of appointment of a director) Not Applicable 6 Information as required under BSE circular Number LIST/COM/14/2018-19 and NSE circular no. NSE/CML/2018/24 dated 20th June, 2018 Not Applicable 7 Letter of resignation along with detailed reason for resignation Not Applicable 8 Names of listed entities in which the resigning Independent Director holds directorships, indicating the category of directorship and membership of board committees, if any. Not Applicable 9 The independent director shall, along with the detailed reasons, also provide a confirmation that there is no other material reasons other than those provided. Not Applicable 10 Confirmation in compliance with SEBI Letter dated June 14, 2018 read along with Exchange Circular dated June 20, 2018 (Affirmation that the person proposed to be appointed as Director is not debarred from holding the office by virtue of any SEBI Order or any other authority) Not Applicable Quick Heal Quick Heal Technologies Ltd. I Corporate Office: 3rd & 4'h Floor, lndiQube Orchid, Plot No. 3A, Shastrinagar, Loop Road, Yerawada, Pune 411 006, MH, INDIA. ~ Registered Office: CTS No. 1442 to 1445, Thube Park, Shivaji Nagar, Pune 41 1 005, MH, INDIA. %. +91 20 66813232 ig contactus@quickheal.com e www.quickhea l.com CIN - L72200MH1995PLC091408
Page 6
A. Quart•rlv and Hair yearl y Financlsl Results QUICK HEAL TECHNOLOGIES LIMITED Regd. Office: S No. 1442 to 1445 Thube Park, Shivajinagar, Pune 411005 CIN: Ln200MH1995PLC091408 STATEMENT OF CONSOLIDATED UNAUDITED FINANCIAL RESULTS OF QUICK HEAL TECHNOLOGIES LIMITED AND ITS SUBSIDIARIES FOR THE QUARTER AND HALF YEAR ENDED SEPTEMBER 30, 2026 ~in CrorC5, uccot camine:s otr share) Quarter ended Halfvear ended Year ended Sr.No. Particulan September 30, 2026 June 30, 2026 September 30, 2025 September 30, 2026 September 30, 2025 March 31, 2026 Unaudited Unaudited Unaudited Unaudited Unaudited /Audited) I Income Revenue from operations 64,93 44.99 83.52 109.92 140.75 261.02 Other income 8.34 14.10 4.38 22.44 10.13 22.83 Total income 73.27 59.09 87.90 132.36 1S0.88 283.8S 2 Expenses Cost of material consumed 0.13 0.49 2.41 0.62 3.27 4.57 Purchase of security software products 0.05 0.01 0.06 0 08 Changes in inventory of security software products 0.67 0,14 (0.16) 0.81 (0.22) (0.37) Employee benefits expense 41.47 43,20 48.58 84.67 92.47 182.90 Finance costs 0.53 - 0 05 0.53 0.11 0.20 Depreciation and amortisation expense 5.78 3,85 3.28 9.63 6.24 13.90 Other expenses 20.31 18.72 23.46 39.03 45.73 103.21 Total expenses 68.94 66.41 77.62 13S.35 147.60 304.49 3 Profit/ (loss) before tax (1-2) 4.33 (7.32) 10.28 (2.99) 3.28 (20.64) 4 Tu expense Current tax 0.21 0.13 0,71 0.34 0.71 0.18 Adjustments of tax relating to earlier periods (Net) (I.60) - (1.60) - - Deferred tax benefit (0.08) (2.17) 1.66 (2.25) 0.17 (9.89) Total tax expense/ (benefit) (1.47) (2.04) 2.37 (3.51) 0.88 (9.71) 5 Profit/ (loss) after tax (3-4) 5.80 (5.28) 7.91 0.52 2.40 (10.93) 6 Other comprehensive income/ (loss) (net of tax) Items that will not be reclassified subsequently to profit or loss : . Gain/ (loss) on re-measurement of defined benefit plans O,Ql 0.04 (0.36) 0.05 (0.06) I 10 Income tax effect - (0.01) 0.09 (0.01) 0.Ql (0.28) 0.01 0.03 (0.27) 0.04 (0.05) 0.82 Net (loss) or gain on FVOCI instruments 0.29 - 0,01 0.29 O,Ql 0.21 Income tax effect (0.04) - (0.04) - (0.03) 0.25 - 0.01 0.25 0.01 0.18 Items that will be reclassified subsequently lo profit or loss : Exchange differences on translation of foreign operations (020) 0,23 0.06 O.Q3 0.15 0.14 Total other comprehensive income/ (loss) for the period 0.06 0.26 (0.20) 0.32 0.11 1.14 7 Total comprehensive income/ (loss) (after tax) (5+6) S.86 (5.02) 7.71 0.84 2.51 (9.79) 8 Paid-up equity share capital (face value oft IO each, fully paid up) 54.27 54.25 54.14 54.27 54.14 54.24 9 Other equity excluding revaluation reserves as per balance sheet - - - 382.28 IO Earnings/ (loss) per share oft 10 each: (not annualised except for the year ended March) a) Basic 1.03 (0.94) L43 0.09 0,43 (1.98) bl Diluted - 1.03 (0.94) 1.42 0.09 0.43 (1.98) 7(e""c~\"\no/c~ . ...,_ / ,, ;; (J"l ~~ :c Pune s- 1) ~-t " ; ;/ ~ I
Page 7
QUICK HEAL TECHNOLOGIES LIMITED Regd. Office: S No. 1442 to 144S Thube Park, Shivajinagar, Pune 41100S CIN: L72200MH199SPLC091408 NOTES TO THE STATEMENT OF CONSOLIDATED UNAUDITED FINANCIAL RESULTS OF QUICK HEAL TECHNOLOGIES LIMITED AND ITS SUBSIDIARIES FOR THE QUARTER AND HALF YEAR ENDED SEPTEMBER 30, 2026 Nole, to financial resulh: I The unaudited consolidated financial results have been prepared m accordance with Indian Accounting S1.and.ards (Ind AS) notified under Section 133 of the Compa,nics Act, 2013 read with the Companies (Indian Accounting Sl4nds.rd Rules). 2015 (as amended) and m terms oj Regulation 33 of SEBl (Listing Obligations and Disclosure Requirements) Regulations 2015 The above financial results for the quarter and half year ended September 30, 2026 have been subjected to limited review by the statutory auditors of the Holding Company and reviewed by the Audit Committee and approved by the Board of Directors of the Holding Company at the meetmg held on October 27, 2026 2 Changes in Key Managerial Personnel of the Holding Company: Mt Sarang Hari Deshpande resigned as Company Secretary w e.f. October 23, 2026 Mr, Shailesh Shinde appointed as Company Secretary we f October 27. 2026 3 AJ at September 30, 2026, the Holding Company has the following subsidiaries : a) Quick Heal Technologies America Inc. b) Seqrite Technologies DMCC 4 For quarter ended June 30, 2026 Other mcome includes l refund of pre-deposit and related interest, aggregating to ~ 6 73 crores, received m connection with Service Tax proceedings under the Finance Act. 1994. The underlying litigation was concluded m favour of the Holding Company during the year ended March 3 1, 2023, and the corresponding refund was received during the quarter ended June 30, 2026. Since the pre-deposit had been charged to the Statement of Profit and Loss in earlier years, the refund thereof has been recognised ilLS Other Income durin.s tht::: quarter 5 On November 21 . 2025 , the Government of India notified the four Labour Codes - the Code on Wages, 2019 , the Industrial Relations Code, 2020, the Code on Social Security, 2020 and the Occupational Safety, Health and Working Conditions Code., 2020 • consolidating 29 ciisti ng !about laws (collectively referred to llS the "New Labour Codes") Based on the requirements of the New Labour Codes and the relevant Accounting Standards, the Holding Company has assessed the impact of these changes and recognised an incremental expense off 1 33 crores under "Employee benefit expense" in the financial results for the )'CJr ended March 31, 2026, primarily on account of recognition of past service cost relating to employee benefit obligations for compensated absences payable to employees The Holding Company continues to monitor the finalization, notification and implementation of State-specific rules and any further clarifications issued by the appropriate authorities in relation to the New Labour Codes and will assess the impact of any future developments as they arise 6 The Group 1s primarily engaged m the business of cyber security software products and related services, including other services. The Chief Operating Decision Maker (CODM) reviews the information pertammg to rc:v-cnue of each of the target customer group (segments) viz c.ansumcr, enterprise and government However, based on similarity of activities/products, risk and reward structure, organisation structure and internal reporting systems, the Group has structured its operations into one operating segment Yiz.. cyber security platfonn and as such there 1s no se-p.uite rcporu.blt operating segment as defined by Ind AS 108 "Operating segments" Entity wide segment disclosures pursuant to Master circular for compliance with the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 201 S by listed enttues as amended from time to time Rt:.,"'Clluc rrom opctatioru fin Crores Parti~"' Ouarur f:fld.t.d Half vr:ar ended Year ended September 30, 2026 June 30, 2026 September 30, 202S September 30, 2026 September 30, 202S March 31, 2026 frt:rrrn ol~ 1\ Unaudited Unaudl1NI Uuudittd Uruudilc-d IAud;,.,o Indira 61.49 41 35 77,83 102.lld 129 98 24.2-26 Oumdo lndio 3.44 J ,64 S.69 7.08 1077 18-76 Tollll 64.93 44,99 83.52 109.92 140.7S 161-02 Non currc.nl u.scts "t in Cron, Particulars A!at S,0 1tmbcr 3li 2026 March 31, 2026 lndu1 163 56 135 78 Outside lndia . Tollll 163.56 135.78 7 Previous period's figures have been regrouped / reclassified wherever necessary to make them comparable with the current period's classification / disclosure_ For and on behalf of the Board ofDirrcton ~~ t9?~r , -..,_ ~,- /',:, , "" Place; Pune v \,~ Chairman & Mana2ine DirccJot O.oc: OclOber 27, 2026 -· ( ~ l DIN No: 00397191 I ..i... '-' ; , r P r I ,._., • - --. I
Page 8
QUICK HEAL TECHNOLOGIES LIMITED Regd. Office: S No. 1442 to 1445 Thube Park, Shivajinagar, Pune 411005 CIN: L72200MH1995PLC091408 STATEMENT OF CONSOLIDATED UNAUDITED ASSETS AND LIABILITIES AS AT SEPTEMBER 30, 2026 Assets Non-current assets (a) Property, plant and equipment (b) Capital work-in-progress ( c) Investment Property (d) Intangible assets (e) Right-of-use assets (f) Financial assets (i) Investments (ii) Other financial assets (g) Deferred tax assets (net) (h) Non-current tax assets (net) (i) Other non-current assets Currenl assets (a) Inventories (b) Financial assets (i) Investments (ii) Trade receivables (iii) Cash and cash equivalents (iv) Bank balances other than (iii) above (v) Other financial assets ( c) Contract assets ( d) Other current assets Total assets Equity and liabilities Equity (a) Equity share capital (b) Share application money pending allotment (c) Other equity Tota l equity Liabilities Non-current liabilities (a) Financial liabilities (i) Lease Liabilities (b) Employee benefit obligations (c) Other non-current liabilities (d) Contract Liabilities Current liabilities (a) Financial liabilities (i) Trade payables (a) Total outstanding dues of micro enterprises and small enterprises (b) Total outstanding dues of creditors other than micro enterprises and small enterprises (ii) Lease Liabilities (iii) Other financial liabilities (b) Employee benefit obi igations ( c) Contract Liabilities (d) Other current liabilities (e) Income tax liabilities (net) Tollll liabilities Total equity and liabilities As at September 30, 2026 (Unaudited) 62.65 125 53.99 0 96 31 ,57 7.79 3 19 19.72 I 1.03 2.16 194.31 I 78 256 32 97.76 5.29 0 10 1.65 3.19 8.73 374.82 569.13 54.27 O.Q3 381 90 436.20 24.40 1.97 0.23 8 43 35.03 0.24 29.17 5.33 2.30 14.34 39.85 6.66 0.01 97.90 132.93 569.13 fin Crores Asat March 31, 2026 (Audited) 87.58 - 32 23 I 25 l 08 7.50 0 81 17.52 25,04 5.33 178.34 2.59 205.19 137,59 13.14 0,10 1.06 3.15 5.83 368.65 546.99 54.24 382.28 436.52 - 1.97 0.21 - 2.18 1.52 39.62 0 11 4.39 20.45 33.82 8.37 0.01 108.29 110.47 546.99
Page 9
Quick Heal Technologies Limited Regd. Office: S No. 1442 to 1445 Thube Park, Shivajinagar, Pune 411005 CIN: L72200MH1995PLC091408 CONSOLIDATED CASH FLOW STATEMENT fin Crores Period ended Period ended Year ended September 30, 2026 September 30, 2025 March 31, 2026 Unaudited Unaudited Audited A. Cash flow from opc_rnting activllics Profil/ (loss) before tax (2.99) 3 28 (20.64) Adju5tmcnt to reconcile profit before 1ax to nc1 cash flows: Net (gain)/ los on foreign exchange difference. 0.20 (0.22) (0 35) Exchange difference on translntion of foreign opcl'tllions 0 03 0.15 0,14 Employee share based payments expense (1.51) 0.63 1.85 Interest on lease 0 53 0.11 0.20 Rent equalisation (0.09) - Depreciation and amortization expense 9.63 6.24 13 90 Interest income (6 25) (0.18) (0 36) Provision for doubtful debts and advances 0 21 7.20 9.48 Bad debts written off 0.03 - 4.24 Property, plant and equipment written off - - 0 15 (Profit)/ loss on sale of property , plant and equipment (2.28) 0.04 (4.99) Income from Investment Property (1 .96) (2.91) (5 13) Net gain on sale of investment (1.48) (0.49) (0.79) Unrealised gain on investments (6.04) (5.84) (10.14) Operating profit/ (loss) before working capital changes (11.88) 7.92 (12.44) Movements in working capital: (Increase)/ decrease in trade receivables 39.40 (16 .08) 15 88 (Increase)/ decrease in inventories 0.81 (0.22) (0 37) (Increase)/ decrease in other financial assets (2.36) (0.38) 0.12 (Increase) in other assets 0.24 (7,87) (4,87) Increase in net employee benefit obligations (6.06) (1.93) 4.65 Increase/ (decrease) in trade payables (11.73) 7 74 6.21 (Decrease) in other financials liabilities (0.22) (0.16) (0 09) Increase in other current and non-current liabilities 12.76 9.13 14.32 Cash (used in)/ generated from operations 20.96 (1.85) 23.41 Income taxes paid (net of refund) 18,63 (3.58) (8.02) Net cash flow (used in)/ generated from operating activities (A) 39.59 (5.43) 15.39 B. Cash flow from investing activities Purchase of property, plant and equipment and intangible assets (including capital work-in-progress (12 57) (13.56) (15.42) and capital advances) Proceeds from sale of property, plant and equipment 7 11 0.06 6.42 Purchase of investment in mutual funds and b~nds (200 ,94) (144.42) (299 ,86) Proceeds from sale of investment in mutual funds 157.33 144.56 277,60 Rental income from investment property 1.95 2.91 4.96 Proceeds from bank deposit other than Cash and cash equivalents (0.08) 0.12 0.12 Interest received 2.36 0.04 0.44 Net cash flow (used in)/ generated from investing activities (B) (44.84) (10.29) (25.74) C. Cash flow from financing activities Principal and interest paid on lease liabilities (3.46) (0 .21) (0.20) Payment of Interest portion of lease liabilities 0.52 . (0.02) Proceeds from issuance of equity shares (including securities premium) on exercise of employee 0,35 1.83 2.98 stock options Net cash flow (used in)/ 11:enerated from financing activities (C) (2.59) 1.62 2.76 Net (Decrease)/ increase in cash and cash equivalents (A+B+C) (7.84) (14.10) (7.59) Cash and cash equivalents at the beginning of the year 13.14 20,84 20.84 Effect of exchange differences on cash and cash equivalents held in foreign currency (0.01) (0,02) (0.11) Cash and cash equivalents at the end of the year 5.29 6.72 13.14 Components or cash and cash equivalents Cash on hand 0 02 0.02 0.o2 Balances with banks On current account 4.37 5.01 11.65 On EEFC account 0,90 1.69 0 62 Deposits with original maturity of less than three months . . 0.08 Cheques on hand '~ < \'Fi':_-,:~,~ 0,77 <> -t1.-"'. 1 "· • ')1r-, " -- Total cash and cash equivalents ,, ' ,,. ~,2-J';,\1\ 5.29 6.72 13.14 // ', /
Page 10
A. Quarterly and Half yearly Financial Results QUICK HEAL TECHNOLOGIES LIMITED Regd. Office: S No. 1442 lo 1445 Thube Park, Shivajinagar, Pune 411005 CJN: L 72200MH1995PLC091408 STATEMENT OF STANDALONE UNAUDITED FINANCIAL RESULTS OF QUICK HEAL TECHNOLOGIES LIMITED FOR THE QUARTER AND HALF YEAR ENDED SEPTEMBER 30, 2026 Cf in Crores. exceot earnine.s oer share) Quarter ended Half year ended Year ended Sr. No. Particulars September 30, 2026 June 30, 2026 September 30, 2025 September 30, 2026 September 30, 2025 March 31, 2026 (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Unaudited) (Audited) I Income Revenue from operations 64.94 44.99 83.52 109.93 140.75 261.06 Other income 8 33 14.12 4_38 22.45 10.13 22 69 Total income 73.27 59.11 87.90 132.38 150.88 283.75 2 Expenses Cost of material consumed 0 12 0 49 244 0 61 3 27 4 57 Purchase of security software products 0.05 0.01 . 0 06 . 0.08 Changes in inventory of security software products 0.66 0 14 (016) 0 80 (0 22) (0 37) Employee benefits expense 41 21 42 93 48 44 8414 92 26 182 17 Finance costs 0,53 . 0.05 0 53 O 11 0 20 Depreciation and amortisation expense 5.78 3.85 3.28 9 63 6 24 13.90 Other expenses 20.59 18.83 23.41 39 42 45 72 103 34 Total expenses 68.94 66.25 77:46 135.19 147.38 303.89 3 Profit/(loss) before tax (1-2) 4.33 (7.14) 10.44 (2.81} 3.50 (20.14) 4 Tax expense Current tax 0.21 0.13 0.71 0 34 0 71 0 18 Adjustments of tax relating to earlier periods (Net) (l.60) . . (1.60) Deferred tax charge/ (benefit) (0.08) (2.17) 1.66 (2.25) 0_17 (9.89) Total tax expense/ (benefit) (1.47) (2.04) 2.37 (3.51} 0.88 (9.71} 5 Profit/ (loss) after lax (3-4) 5.80 (5.10) 8.07 0.70 2.62 (10.43) 6 Other comprehensive income/ (loss) (net of tax) Items that will not be reclassilied subsequently to profit or loss : Gain/ (loss) on re-measurement of defined benefit plans 0.01 0.04 (0.36) 0 05 (0 06) 1,10 Income tax effect (0.01) 0.09 (0_0]} Q_Q] (0.28) 0.01 0.03 (0.27) 0.04 (0.05) 0.82 Net (loss) or gain on FVOCI instruments 0.29 0.01 0.29 001 0,21 Income tax effect (0.04) (0.04) . (0,03) 0.25 . 0.01 0.25 0,01 0.18 Total other comprehensive iocome/ (loss) for the period 0.26 0.03 (0.26) 0.29 (0.04) 1.00 7 Total comprehensive income/ (loss) (after lax) (5+6) 6.06 (5.07) 7.81 0.99 2.58 (9.43) 8 Paid-up equity share capital (face value oH IO each, fully paid up) 54.27 54.25 54.14 54.27 54.14 54.24 9 Other equity excluding revaluation reserves as per balance sheet . 383.00 IO Earnings/ (loss) per share off 10 each: (not annualised except for the year ended March) a) Basic 1.03 (0 91) 1.46 013 0 47 (1.89) b) Diluted 1.03 (0.91) 1.45 0,12 0 47 (I.89) - -
Page 11
QUICK HEAL TECHNOLOGIES LIMITED Regd. Office: S No. 1442 to 1445 Thube Park, Shivajinagar, Pune 411005 CIN: L 72200MH1995PLC091408 NOTES TO THE STATEMENT OF STA LT OF QUlCK HEAL TECHNOLOGIES LIMITED FOR THE Q ARTER AND HALF YEAR ENDED SEPTEMBER 30, 2026 tot.cs to financial results: The unaudited standalone financial results have been prepared in accordance with Indian Accounting Standards (Ind AS) notified wider Section 133 of the Companies Act, 2013 read with the Companies (Indian Accounting Standard Rules), 2015 (as :,mended) and in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, The above financial results for the quarter and half year ended September 30, 2026 have been subjected to limited review by the statutory auditors o the Company and reviewed by the Audit Committee and approved by the Board of Directors of the Company at the meeting held on October 27, 2026. 2 Changes in Key Managerial Personnel of the Company: Mr. Sarang Hari Deshpande resigned as Company Secretary w,e,f October 23, 2026. Mr. Shailesh Shinde appointed as Company Secretary w,e f October 27, 2026 J For the quarter ended June 30, 2026 Other income includes a refund of pre-deposit and related interest. aggregating tot 6, 73 crores, received in connection with Service Tax proceedin gs under the Finance Act. 1994. The underlying litigation was concluded in favour of the Company during the year ended March 3 I, 2023, and the corresponding refund was received during the quarter ended June 30, 2026. Since the pre•deposit had been charged to the Statement of Profit and Loss in earlier years , the refund thereof has been recognised as Other Income during the period. 4 On November 21 , 2025, the Government oflndia notified the four Labour Codes - the Code on Wages, 2019, the Industrial Relations Code, 2020, the Code on Social Security, 2020 and the Occupational Safety, Health and Working Conditions Code, 2020 - consolidating 29 existing labour laws ( collectively referred to as the "New Labour Codes"). Based on the requirements of the New Labour Codes and the relevant Accounting Standards, the Company has assessed the impact of these changes and recognised an incremental expense oft 1.33 crores under "Employee benefit expense" in the financial results for the year ended March 3 I, 2026, primarily on account ofrecognition of past service cost relating to employee benefit obligations for compensated absences payable to employees The Company continues to monitor the finalization, notification and implementation of State•specific rules and any further clarifications issued by the appropriate authorities in relation to the New Labour Codes and will assess the impact of any future developments as they arise. 5 The Company is engaged in providing cyber security software solutions. The Chief Operating Decision Maker (CODM) reviews the information pertaining to revenue of each of the target customer group (segments) viz. consumer, enterprise and govcrnmcnL However, based on similarity of activities/products , risk and reward structure, organisation structure and internal reporting systems , the Company has structured its operations into one operating segment viz. cyber security platform and as such there is no separate reportable operating segment as defined by Ind AS l 08 "Operating segments", 6 Previous period's figures have been regrouped / reclassified wherever necessary to make them comparable with the current period's classification / disclosure, Place: Pune Dale: October 27, 2026. r of the Board of Dirt<:tors ts}5~ Kailash Katkar an & Managing Direc::lor DIN No: 00397191
Page 12
QUICK HEAL TECHNOLOGIES LIMITED Regd. Office: S No. 1442 to 1445 Thube Park, Shivajinagar, Pune 411005 CIN: L72200MH1995PLC091408 STATEMENT OF STANDALONE UNAUDITED ASSETS AND LIABILITIES AS AT SEPTEMBER 30, 2026 Asset Non-current a et.s (11) Property, ptan1 and equipment (b) Capilal work-in-progress (c) l'nves1mcnt property (d) Intangible assets (e) R ght-of-use asseis (I) Investments in subsidiaries (g) Financial assets (I) tnvcstmems (ii) Other fi nancial assets (h) Deferred tax asseis (net) (i) on-current tax assets (net) (D OLher non-current assets Current asselS (a) Inventories (b) Financial assets (!) Investments (ii) Trade receivables (iii) Cash and cash cquiv8lcnts (iv) Bank balances other than (iii) above (v) Other financial asscls (c) Contract assets (d) Other current assets Total asset Equity end liabilities Equity (a) Equity share capital (b) hare application money pending allo1me111 (o) O1hcr equity Total equity Llobilitics Non-current liabilities (a) Financial liabilities (i) Lease Liabilities (b) Employee bencfiL obligations (c) Other non-current liabilities (d) Contract Liabilities Current liabilities (a) Financial liabllilie.s (i) Trade payables• (a) Tomi ou1s1anding dues of micro enterprises and smnll enterprises (b) Total ou1s1anding dues or creditors other than micro en1erpriscs and small enterprises (ii) Lease Liabili1ies (iii) Other financial liabilit cs (b) .Employee benefit obliga1ions (c) Contract Liabilities (d) Other currem liabilities (c) Current lax liabilitie (net) Total liabilities Total cquily uod liabilities Asat September 30, 2026 (Unaudited) 62.63 l 25 53.99 0.96 31.57 0.81 7,79 3.19 19.72 l 1.03 2.16 195.10 1.79 256 32 99.41 4.69 0.10 1,65 3.1 9 8.7! 375.86 570.96 54.27 0.03 382.77 437.07 24.40 1.97 0 23 8.43 JS.OJ 0.24 30.42 5.33 2.10 14.31 39,85 6.60 0,0] 98.86 133.89 570.96 ? in crores As at March 31, 2026 (Audited) 87.58 32.23 1.25 1.08 0.81 7.50 0 81 17.52 25.04 5 33 179.15 2 59 205.19 140.06 11 .97 0.10 1.06 3 15 5.15 369.87 549.02 5424 383.00 437.24 l.97 02 1 2.18 1.52 40.72 0,11 4.28 20.43 33.82 8.71 0.01 109.60 111.78 549.02
Page 13
QUICK HEAL TECHNOLOGIES LIMITED Regd. Office: S No. 1442 to 1445 Thube Park, Shivajinagar, Pune 411005 CIN: L72200MH1995PLC091408 STANDALONE CASH FLOW STATEMENT fin crores Period ended Period ended Year ended September 30, 2026 September 30, 2025 March 31, 2026 Unaudited Unaudited Audited A. Cash flow from operating activities Profit/ (loss) before tax (2.81) 3.50 (20.14) Adjustment to reconcile profit before tax to net cash flows· Net (gain)/ loss foreign exchange differences 0. 19 (0.24) (0.46) Employee share based payments expense (1.51) 0,63 1.85 Interest on lease 0,53 0.11 0.20 Rent equalisation . (0.09) . Depreciation and amortisation expense 9,63 6.24 13.90 Interest income (6.25) (0.18) (0.36) Provision for doubtful debts and advances - 7.05 8.22 Bad debts written off 0.03 4.22 Property, plant and equipment written off - . 0,15 (Profit) on sale of property, plant and equipment (2.28) 0.04 (4,99) Income from Investment property (l.96) (2.91) (5.13) Net gain on sale of investment (I 48) (0.49) (0.79) Unrealised gain on investments (6 04) (5.84) (1014) Operating profit/ (loss) before working capital changes (11.95) 7.82 (13.47) Movements in working capital: (Increase)/ decrease in trade receivables 40.43 (12.68) 18.32 (Increase)/ decrease in inventories 0 80 (0.22) (0.37) (Increase)/ decrease in other financial assets (2.36) (0,39) 0 11 (Increase) in other assets 0.1 8 (7 92) (4.85) Increase in net employee benefit obligations (6.07) (1.91) 4.65 Increase/ (decrease) in trade payables (11 58) 7.58 6.88 (decrease) in other financials liabilities (0 31) (0,21) (0.15) Increase in other current and non-current liabilities 12.36 9.16 14.75 Cash (used in)/ generated from operations 21.50 1.23 25.87 Income taxes paid (net of refund) 18.63 (3,58) (8.02) Net cash flow (used in)/ 2enerated from ooeratin2 activities (A) 40.13 (2.35) 17.85 B. Cash flow from investing activities Purchase of property, plant and equipment and intangible assets (including capital work-in- (12.55) (13.56) (15.42) progress and capital advances) Proceeds from sale of property, plant and equipment 7.11 0 06 6.42 Purchase of investment in mutual funds and bonds (200.94) (144.42) (299.86) Proceeds from sale of investment in mutual funds 157 33 144.56 277.60 Rental income from investment property 1.95 2.91 4.96 Proceeds from bank deposit other than Cash and cash equivalents (0.08) 0.12 0.12 Interest received 2.36 0.04 0.44 Net cash flow (used in) 2enerated from investinl! activities (B) (44.82) (10.29) (25.74) C. Cash flow from financing activities Dividend paid - - . Payment of principal portion oflease liabilities (3.46) (0.21) (0.20) Payment of Interest portion oflease liabilities 0.52 . (0.02) Proceeds from issuance of equity shares (including securities premium) on exercise of 1.83 2.98 employee stock options 0.35 Net cash flow (used in)/ 2enerated from financinl! activities (C) (2.59) 1.62 2.76 Net (Decrease)/ increase in cash and cash equivalents (A+B+C) (7.28) (11.02) (5.13) Cash and cash equivalents at the beginning of the year 11 97 17.10 I 7 10 Cash and cash equivalents at the end of the year 4.69 6.08 11.97 Components of cash and cash equivalents Cash on hand 0.02 0.02 0.02 Balances with banks On current account 3.77 4.37 11.25 On EEFC account 0.90 1.69 0.62 Deposits with maturity of less than 3 months . - 0.08 Total cash and cash equivalents 4.69 6.08 11.97
Page 14
Quick Heal Technologies Limited Reports Q2 FY27 Results Pune, 27th October 2026: Quick Heal Technologies Limited, a global provider of cybersecurity solutions, today announced its unaudited financial results for the quarter and half year ended September 30, 2026. Key Financial Highlights Particulars (₹ Cr) Q2 FY26 Q1 FY27 Q2 FY27 Revenue 83.5 45.0 64.9 EBITDA 9.2 (17.6) 2.3 EBITDA Margin 11.1% -39.1% 3.5% PAT 7.9 (5.3) 5.8 PAT Margin 9.5% (11.7%) 8.9% Harish Kumar G S , Chief Executive Officer, Quick Heal Technologies Limited, said: "Q2 marks an important step forward as we sharpen execution across the organization. Our focus is increasingly on translating Quick Heal’s strong technology foundation, customer trust and cybersecurity capabilities into consistent business outcomes. The Enterprise business continues to demonstrate resilience, supported by our expanding cybersecurity portfolio and traction across strategic sectors. As we enter the second half of FY27, our priorities are clear: sharpen our go -to-market by product portfolio and customer segment, strengthen execution discipline, and accelerate innovation and market penetration across cybersecurity, data protection and emerging digital risks. We believe these actions will create a stronger foundation for sustainable, profitable growth." Ankit Maheshwari, Chief Financial Officer, Quick Heal Technologies Limited, added: "Our Q2 performance reflects a meaningful improvement in operating performance, with the Company returning to positive EBITDA and PAT. We remain focused on balancing investments for future growth with financial discipline and improved operating efficiency. The Enterprise business continues to provide a resilient base, while tighter credit controls and collections remain an important priority in the Consumer business. Total receivables reduced further to ₹97.8 Cr during Q2 FY27 from ₹106.6 Cr in Q1 FY27. We remain focused on building on the improvement in operating performance, strengthening cash flows and driving a better quality of earnings through disciplined and efficient growth." Quick Heal
Page 15
Strategic Highlights of Q2 FY27 include: • Strategic customer wins across Defence, BFSI and a large IT services company through the Company’s new-generation products during H1 FY27. • Appointed Rajiv Sreekantan, to lead Enterprise growth as the company scales its enterprise GTM, expands globally, and accelerates its AI-powered next-generation cybersecurity portfolio. • Appointed Amit Chaudhary as Vice President – Product Management, to strengthen product strategy, accelerate innovation, and build customer -centric cybersecurity and data privacy solutions. • Healthy order visibility: Enterprise order book of ₹57 Cr+. • Improved collections: Total overdue reduced by nearly ₹78 Crs since H1FY26. • Continued implementation of tighter credit controls in the Consumer business. • Seqrite Flags SVG File Abuse as Emerging Stealth Attack Vector targets Indian Enterprises As the Company progresses through FY27, it will continue to focus on strengthening its cybersecurity portfolio and delivering value to customers across consumer and enterprise businesses. About Quick Heal Technologies Limited Quick Heal Technologies Limited is a leading global cybersecurity solutions provider. Incorporated in 1995 with a registered office in Pune, it offers end -to-end cybersecurity solutions across B2C, B2B, and B2G segments. With its widely recognized brands ‘ Quick Heal’ and ‘Seqrite ’, the company provides AI - powered, patented technologies that protect endpoints, networks, data, mobility, and cloud environments. Committed to R&D and innovation, Quick Heal Technologies continues to simplify security by delivering best -in-class protecti on against advanced cyber -threats to millions of customers, enterprises, and government organizations worldwide. Quick Heal
Page 16
www.quickheal.com | www.seqrite.comConfidential Please find below the colour palette for this presentation: Select an object / Shape > Go to shape fill > Select eye dropper tool. Pic any colour from the palette. Q2 FY27 October 27, 2026 EARNINGS PRESENTATION
Page 17
Confidential 2 2 GLOBAL CYBERSECURITY TRENDS • Investment & adoption of AI in Cybersecurity • Consolidation of security stack • Privacy driven Application & Data Decoupling • Growing Adoption of Cloud Native Application • Cybersecurity reskilling • Organizations continue to accelerate their multiyear Security Service Edge (SSE) and Zero Trust (ZT) journey • Organizations continue to strengthen their security portfolio with new tools SECRITE I Quick Heal •
Page 18
Confidential 3 3 INDIA CYBER THREAT REPORT: KEY HIGHLIGHTS Primary attack vectors 70% of attacks originated from Trojans and Infectors On-Prem detections contributed 92% while 8% detections were cloud~12 attacks per month per personal end user device Bigger spectrum of detections and endpoints Over 265.52 M detections recorded over8 Million endpoints detections Averaging 505 per minute Behavioral-based detection Increase from 12.5% in 2023 34 million 12.8 % of total detections behavior-based detections, accounted for Source: India Cyber Threat Report 2026 SECRITE I Quick Heal
Page 19
Confidential 4 4 INDIA CYBER THREAT REPORT: KEY HIGHLIGHTS CONTD… Approximately 5 million Cryptojacking detections reported over the year 1 Ransomware incident per 669 detections 1 Malware incident per 42,012 detections Malware and Ransomware incidents Education & Training Healthcare Engineering & Manufacturing 23.8% 18.3% 18.3% Top-most targeted industries Geographical Hotspots 24.3% of detections Maharashtra 16.2% of detections Gujarat 10.4% of detections Delhi NCR 9.7% of detections West Bengal 9.4% of detections Uttar Pradesh Source: India Cyber Threat Report 2026 SECRITE I Quick Heal
Page 20
Confidential 5 5 OUR PURPOSE Innovate Focus on grassroot research and adoption of new tech Simplify Ease of manageability & operations for the end customers Secure Getting the Job Done: Staying one step ahead of the threat actors to protect our customers Innovate to “simplify” securing digital experience SECRITE I Quick Heal 0
Page 21
Confidential 6 6 OUR JOURNEY SO FAR Protected early Generations of PCs 1993-96 Secured PCs, Network & Emails 1996-00 Ensured a safe digital experience for Individuals, Businesses and Government Organizations 2001-05 Threat protection for Smart Phones and Tablets 2006-10 Recognised by NASSCOM’s DSCI as ‘Cyber security Product pioneer in India’ 2017-19 Protecting Data, Transactions & Cloud transitions 2020-23 • CSMA Product Stack • Collaboration with AISIC and NIST- NCCOE • India Cyber Threat Report • Seqrite Brand Refresh • Anti Fraud Launch • International Expansion • Expansion into Privacy & Data Protection 2023-26 SECRITE I Quick Heal
Page 22
Confidential 7 7 THIS IS US Pioneer of cybersecurity in India Presence in 70+ countries 1st Listed Cybersecurity company in India Protecting 9 Million Active Devices ~1000 Cybersecurity Professionals Market Leader in India Patents Protecting Critical Infrastructure of India Collaborators with US bodies NIST & AISIC Proud Owners of Seqrite Labs: Largest in the country ••• --- - e SECRITE I Quick Heal
Page 23
Confidential 8 8 FOUNDED BY THE VISIONARIES Dr. Kailash Katkar Chairman and Managing Director Dr. Sanjay Katkar Joint Managing Director A Visionary Founder and Leader, a Born Entrepreneur, and an Exemplary Trailblazer, he has transformed Quick Heal into a beacon of success and innovation in the Cybersecurity industry. His business acumen has consistently driven Remarkable financial performance, customer satisfaction, market leadership making Quick Heal & SEQRITE the preferred choice for customers globally. Dr. Sanjay Katkar: Co- Founder of Quick Heal Technologies Limited, Joint Force, and Technology Powerhouse behind the company's journey. An unmatched Cybertech Mastermind, who is relentlessly shaping the company’s global technology strategy and driving core research and development while pursuing product innovation to fortify cyber security. SECRITE I Quick Heal Dr. Kailash Katkar Dr. San jay Katkar
Page 24
Confidential 9 9 LED BY THE INDUSTRY EXPERTS Harish Kumar Chief Executive Officer Ankit Maheshwari Chief Financial Officer Anupama Katkar COE at QH & Chairperson QHF Rajiv Sreekantan Senior Vice President Enterprise Sales Netra Deshpande Head of Engineering Sangamesh S Head of Seqrite Labs Amit Chaudhary Vice President – Product Management Deepak Mishra Head, Retail Sales Nitin Bhogan Head of Academy Ashish Kadam Director, Government Sales Amartya Mukherjee Vice president & Head of Delivery Savita Nehra Vice President, People & Culture Rohit Kachroo Sr Director, IT & Digital Transformation An industry veteran with over three decades of experience in the technology sector, Harish has a proven track record of driving growth, scaling up iconic brands, and building high-performance teams. He is focused on strengthening Quick Heal's position as a trusted cybersecurity leader through innovation, customer-centricity, and operational excellence. SECRITE I Quick Heal Ankit Anupama Rajiv Netra SangameshS Amit Maheshwari Katkar Sreekantan Deshpande Chaudhary Harish Kumar Chief Financial COE at OH & Senior Vice President Head of Head of Seqrite Vice President - Chief Executive Officer Officer Chairperson QHF Enterprise Sales Engineering Labs Product Management Rohit Deepak Amartya Savita Nitin Ashish Kachroo Mishra Mukherjee Nehra Bhogan Kadam Sr Director, IT & Digital Head, Vice president & Vice President, Head of Director, Transformation Retail Sales Head of Delivery People & Culture Academy Government Sales
Page 25
Confidential 10 10 OUR STRATEGY & WAY FORWARD SECRITE I Quick Heal
Page 26
Confidential 11 11 EXPANDING ACROSS 3 LEVERS Product Stack Holistic cybersecurity stack for better protection and increased wallet share Large Customers Moving up the customer segments as the solutions mature Niche Solutions specifically targeted to Large Enterprises (SDP) and Mid Enterprises (Threat Management) Geographic Reach Setting up a strong foot in Indian Market Strategic Expansion in select focused geographies SECRITE I Quick Heal
Page 27
Confidential 12 12 SEQRITE SOLUTION STACK An approach to simplify cybersecurity by integrating security tools across a distributed enterprise SECRITE I Quick Heal
Page 28
Confidential 13 13 OUR RIGHT TO WIN • Solving unique value propositions & use cases (E.g.: On prem & cloud) • Best in class support offerings • Largest Cybersecurity Lab in India with unique telemetry • Simple Integrated Architecture • Adoption of the new age tech in our stack • Holistic platformised cybersecurity solution • Strong Partner Network across the country • Make in India • Proximity to the customers in India SECRITE I Quick Heal
Page 29
Confidential 14 14 AWARDS & RECOGNITIONS Quick Heal is certified as one of the safest for browsing & banking by AVLab, Poland Quick Heal is certified the “Product of the year” by AVLab, Poland Seqrite Endpoint Protection for Best Performance by AV-Test Seqrite Endpoint Protection Achieves AV- TEST Approved – Top Product - Corporate Endpoint Protection SECRITE I Quick Heal
Page 30
Confidential 15 Q2 FY27 BUSINESS HIGHLIGHTS
Page 31
Confidential 16 16 BUSINESS HIGHLIGHTS • Key strategic account wins in Defense, BFSI & large IT services company through our new gen products in H1 • Strong momentum in the government vertical • Order Book: INR 57 Cr+ • Deferred Revenue: INR 48.3 Cr (Q1FY27: 52.3 Cr) • Tighter credit controls in the Consumer business • Onboarding of Key Leadership across Sales & Product functions SECRITE I Quick Heal
Page 32
Confidential 17 17 Q2 FY27: PERFORMANCE HIGHLIGHTS *Based on gross revenues excluding deferred revenue, before adjusting for sales incentives ₹ 64.9 Cr Net Revenue -22.3% YoY 44.3% QoQ ₹ 2.3 Cr EBITDA -75.2% YoY 113.0% QoQ ₹ 5.8 Cr PAT -26.8% YoY 209.7% QoQ ₹ 1.0 Diluted EPS -27.4% YoY 209.2% QoQ ₹ 35.5 Cr * Enterprise Revenue -3.9% YoY 18.1% QoQ ₹ 35.8 Cr * Consumer Revenue -39.8% YoY 86.2% QoQ SECRITE I Quick Heal
Page 33
Confidential 18 18 DECONSTRUCTING CURRENT BUSINESS ConsumerEnterprise 46% 54% FY 2021 H1 FY 2027FY 2026 49%51% 80% 20% SECRITE I Quick Heal ■ ■
Page 34
Confidential 19 19 ENTERPRISE BUSINESS CLOUD & ON-PREM 38% 62% 31% 69% FY 2025 FY 2026 H1 FY2027 Cloud On-Prem 31% 69% SECRITE I Quick Heal ■ ■
Page 35
Confidential 20 20 KEY FINANCIAL HIGHLIGHTS Gross Revenue Consumer Gross Revenue Enterprise Total Deferred Revenue All figures in INR Cr Total Receivables 37 30 36 Q2FY26 Q1FY27 Q2FY27 +18% 60 19 36 Q2FY26 Q1FY27 Q2FY27 +86% 18 52 48 Q2FY26 Q1FY27 Q2FY27 -8% 176 107 98 Q2FY26 Q1FY27 Q2FY27 -8% SECRITE I Quick Heal
Page 36
Confidential 21 21 SEQRITE: ENTERPRISE ARM OF QUICK HEAL FY16 FY23-24 FY25FY17 – 22 FY26-27 • Investments in EDR, XDR, Zero Trust & Data Privacy products • Crossed 100 Cr in revenue • Mid-Market Capture SMB Market Capture & Leadership Foray into Enterprise Segment with Seqrite Endpoint Protection • Horizon-3 Product • Material New Product Revenue • Projects & Order Book • SIA Launch • Government segment penetration • International Expansion • Data Privacy Market Entry • DRPS and RRaaS launched SECRITE I Quick Heal
Page 37
23rd Elets NBFC100 Tech Summit, Chennai | 9 July 2026 Seqrite + JISA Webinar: Implementing DPDP the Right Way | 23 July 2026 Kerala Cyber Suraksha Summit (KCSS) 2026, Kochi | 5 September 2026 15th GISEC Global 2026, Dubai | 16-18 September 2026 ENTERPRISE MARKETING CAMPAIGNS SECRITE I Quick Heal
Page 38
Confidential 23 23 MARKET LEADER: CONSUMER ANTIVIRUS BUSINESS Positioning AntiFraud.AI to tackle the financial frauds Focus towards maintaining our market share in AV segment Drive consumer awareness in the geography in cybersecurity specific domain 30 years into existence Market leadership with over 30% in the Indian market Robust Sales & Distribution network in India Our Approach: SECRITE I Quick Heal • • 0 QUICK HEAL QUICK HEAL ' • INTERNET SECURITY TOTAL SECURITY QUICK HEAL ANTIVIRUS PRO • C ;; 0 . ~ ~ • ; z • ~ ~ i ~ • -4) -, ,.,. ,..,,,,_ ,.,.,_ I~ "" -.,p11111K! •
Page 39
Confidential 24 24 CONSUMER MARKETING CAMPAIGNS Festive activities Student Campaign Partner Communications Booster for Sales - T3 partner COMPLETE YOUR ACT IVATIONS . Exer11g1vE REWARD How to Earn Your Reward !ll01 !ll02 !ll03 !ll04 Purchase Activate Enaurelhe Receive ■ QuickHoat 50% lirstacanis Porta ble products dooethrO!Jlh &tender& worth (~22,000) the RPP Pot"Ut Julc:erworth ~44.000 durlngthe ~4.999 scheme period Importan t Deta ils $(;heme PwiOd: 1 -31 Ck:tober 2026 I °'PP!H;8bl ■ tor Rqi sterlld T3 Panner1 Eli&ibtlity based on the llrst scan ,n the RPP Portal I o,tts will be d1spatc;hecl to the reaisterad partner address I •ontyooe aitt will De awarded per eUIJbte dealer. For mor•d•U11l1 callYoVrArea Sales Manager oeeo i'!uld<hNI Here's to every first click that brings celebration clos SECRITE I ~ SECRITE l l:m:m ■ 'l'lioln.Aoo;,-~ Contro l and restrict You Tube access across all business device s. ..... . 0 SECRITE I Quick Heal
Page 40
Confidential 25 25 CSR UPDATE Maharashtra, Karnataka, Gujarat, West Bengal, Chhattisgarh, Uttar Pradesh, Assam, Punjab, Jammu & Kashmir, Madhya Pradesh, Kerala , Goa, Odisha, Haryana, Tamil Nadu, Rajasthan, Bihar, Jharkhand, Puducherry Total Outreach 1 Cr+ Cyber Shiksha for Cyber Suraksha Total States Covered 19 SECRITE I Quick Heal
Page 41
Confidential 26 Q2 FY27 FINANCIAL HIGHLIGHTS
Page 42
Confidential 27 27 CONSOLIDATED P&L All figures in INR Cr PARTICULARS Q2 FY26 Q1 FY27 Q2 FY27 Revenue 83.5 45.0 64.9 Direct Cost 2.6 0.8 4.3 Gross Profit 81.0 44.2 60.7 Gross Margin 96.9% 98.2% 93.5% Operating Cost Research and Development 32.9 28.1 27.1 Sales and Marketing 22.5 20.9 19.1 General Administration 16.3 12.8 12.2 Total Expenditure 71.7 61.8 58.4 EBITDA 9.2 (17.6) 2.3 EBITDA % 11.1% -39.1% 3.5% Depreciation 3.3 3.9 5.8 EBIT 6.0 (21.4) (3.5) Other Income 4.4 14.1 8.3 Finance Cost (0.1) 0.0 (0.5) Profit Before Tax (PBT) 10.3 (7.3) 4.3 Tax 2.4 (2.0) (1.5) Profit After Tax (PAT) 7.9 (5.3) 5.8 PAT Margin 9.5% -11.7% 8.9% H1 FY26 H1 FY27 140.8 109.9 3.5 5.0 137.3 104.9 97.5% 95.4% 64.2 55.2 43.6 40.0 30.0 25.0 137.8 120.2 (0.5) (15.3) -0.4% -13.9% 6.2 9.6 (6.7) (24.9) 10.1 22.4 (0.1) (0.5) 3.3 (3.0) 0.9 (3.5) 2.4 0.5 1.7% 0.5% SECRITE I Quick Heal
Page 43
Confidential 28 28 BALANCE SHEET All figures in INR Cr ASSETS Mar 31, 2026 Sep 30, 2026 Non-Current Assets: Property, plant and equipment 87.6 62.7 Capital work-in-progress 0.0 1.3 Intangible assets 1.3 1.0 Investment Property 32.2 54.0 Right-of-use assets 1.1 31.6 Non-current financial assets Investments in MF, Tax-Free Bonds & others 7.5 7.8 Other Financial Asset 0.8 3.2 Deferred tax assets (net) 17.5 19.7 Income tax assets (net) 25.0 11.0 Other Non Current assets 5.3 2.2 Total Non-Current Assets 178.3 194.3 Current assets: Inventories 2.6 1.8 Investments 205.2 256.3 Trade and other receivables 137.6 97.8 Cash and Cash Equivalents 13.1 5.3 Bank Balance other than cash & cash equivalents 0.1 0.1 Other Financial Assets 1.1 1.7 Other Current assets 9.0 11.9 Total Current Assets 368.7 374.8 Total Assets 547.0 569.1 EQUITY AND LIABILITIES Mar 31, 2026 Sep 30, 2026 Equity Equity Share Capital 54.2 54.3 Other Equity 382.3 381.9 Total Shareholder Funds 436.5 436.2 Non-Current Liabilities Lease Liabilities - 24.4 Employee benefit obligations 2.0 2.0 Other Non Current Liabilities 0.2 8.7 Total Non-Current Liabilities 2.2 35.0 Current Liabilities: Trade and Other Payables 41.1 29.4 Other Financial Liabilities 4.5 7.6 Contract Liabilities 33.8 39.9 Other Current Liabilities 8.4 6.7 Employee benefit obligations 20.5 14.3 Total Current Liabilities 108.3 97.9 Total Equity & Liabilities 547.0 569.1 SECRITE I Quick Heal
Page 44
Confidential 29 29 CASH FLOW STATEMENT All figures in INR Cr PARTICULARS Sep 30, 2025 Mar 31, 2026 Sep 30, 2026 Net cash flow from / (used in) operating activities (A) (5.4) 15.4 39.6 Net cash flow from / (used in) investing activities (B) (10.3) (25.7) (44.8) Net cash flow from / (used in) financing activities (C) 1.6 2.8 (2.6) Net (decrease) in cash and cash equivalents (A+B+C) (14.1) (7.6) (7.9) Cash and cash equivalents at the beginning of the period 20.8 20.8 13.1 Effect of exchange differences on cash and cash equivalents held in foreign currency (0.0) (0.1) - Cash and cash equivalents at the end of the period 6.7 13.1 5.3 Components of cash and cash equivalents Cash in hand 0.0 0.0 0.0 Balances with banks and cheques on hand 6.7 13.1 5.3 Total cash and cash equivalents 6.7 13.1 5.3 SECRITE I Quick Heal
Page 45
Confidential Stock Market Performance (as on 30th September2026) Price Data (as of 30th September 2026) Face Value 10.00 Market Price 144.85 52 Week H/L 371.00/125.00 Market Cap (INR Mn) 7,863.51 Equity Shares Outstanding (Mn) 54.27 1 Year Avg. Trading Volume ('000) 593.14 1 Year Avg. Net Turnover (Mn) 135.62 -80% -60% -40% -20% 0% 20% 40% Oct-25 Nov-25 Dec-25 Jan-26 Feb-26 Mar-26 Apr-26 May-26 Jun-26 Jul-26 Aug-26 Sep-26 Sensex Quick Heal-BSE Promoter, 71% Other, 5% Public, 24% Shareholding Pattern (as on 30th September 2026) CAPITAL MARKET DATA
Page 46
Confidential 31 31 DISCLAIMER Quick Heal Technologies Limited No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness, or correctness of the information or opinions contained in this presentation. Such information and opinions are in all events not current after the date of this presentation. Certain statements made in this presentation may not be based on historical information or facts and may be "forward-looking statements" based on the currently held beliefs and assumptions of the management of Quick Heal Technologies Limited, which are expressed in good faith and in their opinion reasonable, including those relating to the Company’s general business plans and strategy, its future financial condition and growth prospects and future developments in its industry and its competitive and regulatory environment. Forward-looking statements involve known and unknown risks, uncertainties, and other factors, which may cause the actual results, financial condition, performance, or achievements of the Company or industry results to differ materially from the results, financial condition, performance, or achievements expressed or implied by such forward-looking statements, including future changes or developments in the Company’s business, its competitive environment, and political, economic, legal and social conditions. Further, past performance is not necessarily indicative of future results. Given these risks, uncertainties, and other factors, viewers of this presentation are cautioned not to place undue reliance on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements to reflect future events or developments. This presentation is for general information purposes only, without regard to any specific objectives, financial situations, or informational needs of any particular person. This presentation does not constitute an offer or invitation to purchase or subscribe for any securities in any jurisdiction, including the United States. No part of it should form the basis of or be relied upon in connection with any investment decision or any contract or commitment to purchase or subscribe for any securities. None of our securities may be offered or sold in the United States, without registration under the U.S. Securities Act of 1933, as amended, or pursuant to an exemption from registration therefrom. This presentation is confidential and may not be copied or disseminated, in whole or in part, and any manner. Valorem Advisors Disclaimer: Valorem Advisors is an Independent Investor Relations Management Service company. This Presentation has been prepared by Valorem Advisors based on information and data which the Company considers reliable, but Valorem Advisors and the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness, and reasonableness of the contents of this Presentation. This Presentation may not be all-inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. Valorem Advisors also hereby certifies that the directors or employees of Valorem Advisors do not own any stock in personal or company capacity of the Company under review. SECRITE I Quick Heal
Page 47
www.quickheal.com | www.seqrite.comConfidential Please find below the colour palette for this presentation: Select an object / Shape > Go to shape fill > Select eye dropper tool. Pic any colour from the palette. THANK YOU
Page 48
MSKA & Associates LLP (Formerly known as MS KA & Associates) Chartered Accountants Floor 6, Building No. 1 Cerebrum IT Park, Kalyani Nagar Pune 411014, INDIA Independent Auditor's Review Report on consolidated unaudited financial results of Quick Heal Technologies Limited for the quarter and year to date September 30, 2026 pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended To the Board of Directors of Quick Heal Technologies Limited 1. We have reviewed the accompanying Statement of consolidated unaudited financial results of Quick Heal Technologies Limited (hereinafter referred to as 'the Holding Company'), its subsidiaries, (the Holding Company and its subsidiaries together referred to as the 'Group') for the quarter ended September 30, 2026 and the year to-date results for the period from April 01, 2026 to September 30, 2026 ('the Statement') attached herewith, being submitted by the Holding Company pursuant to the requirements of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ('the Regulations'). 2. This Statement, which is the responsibility of the Holding Company's Management and approved by the Holding Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 'Interim Financial Reporting' prescribed under Section 133 of the Companies Act, 2013 ('the Act') read with relevant rules issued thereunder (' Ind AS 34') and other recognised accounting principles generally accepted in India and is in compliance with the Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under section 143(10) of the Act and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. We also performed procedures in accordance with the circular issued by the Securities and Exchange Board of India under Regulation 33 (8) of the Regulations, to the extent applicable. 4. This Statement includes the results of the Holding Company and the following entities: 2 Sr. No Name of the Entity Relationship with the Holding Company Quick Heal Technologies America Inc. Wholly owned subsidiary Seqrite Technologies DMCC Wholly owned Registered Office : 602, Raheja Titanium , Western Express Highway, Goregaon (East), Mumbai-400063, Maharashtra, India Tel: +91 22 6974 0200 I LLPIN: ACT-3789 Ahmedabad I Bengaluru I Chandigarh I Chennai I Coimbatore I Goa I Gurugram I Hyderabad I Kochi I Kolkata I Mumbai www.mska.in
Page 49
MSKA & Associates LLP (Formerly known as MS KA & Associates) Chartered Accountants 5. Based on our review conducted and procedures performed as stated in paragraph 3 above nothing has come to our attention that causes us to believe that the accompanying Statement prepared in accordance with the recognition and measurement principles laid down in Ind AS 34 and other recognised accounting principles generally accepted in India has not disclosed the information required to be disclosed in terms of the Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. 6. The Statement includes the interim financial information of two subsidiaries which are not subject to review, whose interim financial information reflects total assets of Rs. 5.18 Crores as at September 30, 2026 and total revenue of Rs. 0.51 Crores and Rs. 0. 90 Crores , total net loss after tax and total comprehensive loss of Rs. 0. 12 Crores and Rs. 0. 13 Crores for the quarter ended September 30, 2026, and for the period from April 01, 2026 to September 30, 2026 , respectively, and cash outflow of Rs. (0.58) Crores for the period from April 01, 2026 to September 30, 2026, as considered in the Statement. This interim financial information has been furnished to us by the Management and our conclusion on the Statement in so far as it relates to the amounts and disclosures included in respect of these subsidiaries is based solely on such management prepared unaudited interim financial information. According to the information and explanations given to us by the Management, this interim financial information is not material to the Group. Our conclusion is not modified in respect of the above matter with respect to our reliance on the financial result certified by the management. For MS KA & Associates LLP (Formerly known as MS KA & Associates) Chartered Accountants ICAI Firm tration No. 105047W /W101187 r oJ...&:' ~ -t;;'9 • Shr ddha D Khivasara Partner Membership No.: 134285 q ~ 2- UDIN: ib l3~ 2515f ~!PPS 2- :J Place: Pune Date: October 27, 2026 Registered Office: 602, Raheja Titanium, Western Express Highway, Goregaon (East), Mumbai-400063, Maharashtra, India Tel: +91 22 6974 0200 I LLPIN: ACT-3789 Ahmedabad I Bengaluru I Chandigarh I Chennai I Coimbatore I Goa I Gurugram I Hyderabad I Kochi I Kolkata I Mumbai I Pune www.mska.in
Page 50
MSKA & Associates LLP (Formerly known as MS KA & Associates) Chartered Accountants Floor 6, Building No. 1 Cerebrum IT Park, Kalyani Nagar Pune 411014, INDIA l ,,· Independent Auditor's Review Report on Standalone unaudited financial results of Quick Heal Technologies Limited for the quarter and year to date September 30, 2026, pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. To The Board of Directors of Quick Heal Technologies Limited. 1. We have reviewed the accompanying statement of standalone unaudited financial results of Quick Heal Technologies Limited (hereinafter referred to as 'the Company'), for the quarter ended September 30, 2026 and the year to-date results for the period from April 01, 2026 to September 30, 2026 ('the Statement') attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ('the Regulations'). 2. This Statement, which is the responsibility of the Company's Management and has been approved by the Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 'Interim Financial Reporting', prescribed under Section 133 of the Companies Act, 2013 ('the Act') read with relevant rules issued thereunder (' Ind AS 34') and other recognised accounting principles generally accepted in India and is in compliance with the Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under section 143(10) of the Act and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express_ an audit opinion. ,,.. (This space has been left blank intentionally) Registered Office: 602, Raheja Titanium, Western Express Highway, Goregaon (East), Mumbai-400063, Maharashtra, India Tel: +91 22 6974 0200 I LLPIN: ACT-3789 Ahmedabad I Bengaluru I Chandigarh I Chennai I Coimbatore I Goa I Gurugram I Hyderabad I Kochi I Kolkata I Mumbai www.mska.in
Page 51
MSKA & Associates LLP (Formerly known as MS KA & Associates) Chartered Accountants Floor 6, Building No. 1 Cerebrum IT Park, Kalyani Nagar Pune 411014, INDIA 4. Based on our review conducted as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement prepared in accordance with the recognition and measurement principles laid down in Ind AS 34 and other recognised accounting principles generally accepted in India has not disclosed the information required to be disclosed in terms of the Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement . For MS KA & Associates LLP (Formerly known as MS KA & Associates) Chartered Accountants ICAI Firm~ ration No.105047W /W101187 Ct>-.~ ,. ~ ~ ~ Shraddha D Khivasara Partner Membership No.: 134285 A" Lqq go UDIN:2.Gt34~<35RLU " 1 Place: Pune Date: October 27, 2026 Registered Office: 602, Raheja Titanium, Western Express Highway, Goregaon (East), Mumbai-400063, Maharashtra, India Tel: +91 22 6974 0200 [ LLPIN: ACT-3789 Ahmedabad I Bengaluru I Chandigarh I Chennai I Coimbatore I Goa I Gurugram I Hyderabad I Kochi I Kolkata I Mumbai www.mska.in